Want to see JP:6523 full AI Analyst Report?
6523 Stock Chart & Stats
¥1112.00
¥4.00(0.41%)
At close: 4:00 PM EST
¥1112.00
¥4.00(0.41%)
Day’s Range― - ―
52-Week Range¥942.00 - ¥1,694.00
Previous CloseN/A
Volume174.10K
Average Volume (3M)1.29M
Market Cap
¥180.17B
Enterprise Value¥317.86B
Total Cash (Recent Filing)¥41.28B
Total Debt (Recent Filing)¥229.26B
Price to Earnings (P/E)19.5
Beta0.78
Next Earnings
Nov 11, 2026EPS Estimate
45.22Next Dividend Ex-DateN/A
Dividend Yield2.97%
Share Statistics
EPS (TTM)72.45
Shares Outstanding127,327,580
10 Day Avg. Volume1,090,850
30 Day Avg. Volume1,289,470
Financial Highlights & Ratios
PEG Ratio-2.94
Price to Book (P/B)0.85
Price to Sales (P/S)0.38
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,650.00Price Target Upside48.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)170.42
Revenue Forecast (FY)¥372.72B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationPHC generates substantial operating and free cash flow despite thin reported earnings, indicating healthy cash conversion from its healthcare operations. Sustained cash production can support debt service, ongoing investment, and customer support while providing resilience across the next several quarters.
Stable Gross MarginsConsistent gross margins of roughly 45–48% indicate that PHC retains reasonable product economics across its medical devices, diagnostics, and healthcare equipment portfolio. Margin stability provides a durable foundation for operating investment and potential earnings recovery if profitability improves.
Recurring Consumables And ServicesPHC combines capital equipment sales with repeat demand for diagnostic reagents, diabetes test strips, and after-sales services. This installed-base model can deepen customer relationships and make part of revenue more recurring than one-time equipment purchases alone.
Bears Say
Near-Breakeven Net ProfitabilityVery thin net profitability shows that PHC is not consistently converting solid gross margins and positive operating earnings into durable bottom-line returns. This limits internal capital formation and leaves earnings more vulnerable to cost, financing, or operating pressures.
Elevated LeverageAlthough leverage has improved from prior years, debt remains high for a medical devices company and operating cash flow covers only a modest portion of total debt. This constrains financial flexibility and can limit investment capacity while profitability remains weak.
Limited Revenue GrowthRevenue growth remains modest rather than demonstrating strong expansion across PHC’s healthcare markets. A largely stable top line makes future earnings improvement more dependent on efficiency and margin gains, while limiting the operating leverage available from faster sales growth.
PHC Holdings Corp. News
6523 FAQ
What was PHC Holdings Corp.’s price range in the past 12 months?
PHC Holdings Corp. lowest stock price was ¥942.00 and its highest was ¥1694.00 in the past 12 months.
What is PHC Holdings Corp.’s market cap?
PHC Holdings Corp.’s market cap is ¥180.17B.
When is PHC Holdings Corp.’s upcoming earnings report date?
PHC Holdings Corp.’s upcoming earnings report date is Nov 11, 2026 which is in 11 days.
How were PHC Holdings Corp.’s earnings last quarter?
PHC Holdings Corp. released its earnings results on Aug 06, 2026. The company reported ¥50.06 earnings per share for the quarter, beating the consensus estimate of ¥21.97 by ¥28.09.
Is PHC Holdings Corp. overvalued?
According to Wall Street analysts PHC Holdings Corp.’s price is currently Undervalued.
Does PHC Holdings Corp. pay dividends?
PHC Holdings Corp. pays a Semiannually dividend of ¥21 which represents an annual dividend yield of 2.97%. See more information on PHC Holdings Corp. dividends here
What is PHC Holdings Corp.’s EPS estimate?
PHC Holdings Corp.’s EPS estimate is 45.22.
How many shares outstanding does PHC Holdings Corp. have?
PHC Holdings Corp. has 127,327,580 shares outstanding.
What happened to PHC Holdings Corp.’s price movement after its last earnings report?
PHC Holdings Corp. reported an EPS of ¥50.06 in its last earnings report, beating expectations of ¥21.97. Following the earnings report the stock price went up 1.115%.
Which hedge fund is a major shareholder of PHC Holdings Corp.?
Currently, no hedge funds are holding shares in JP:6523
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PHC Holdings Corp.
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
6523 Stock 12 Month Forecast
Average Price Target
¥1,650.00
▲(48.38% Upside)
Technical Analysis
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―

